Omega Therapeutics Inc (NASDAQ:OMGA) — Market Cap & Net Worth
Market Cap & Net Worth: Omega Therapeutics Inc (OMGA)
Omega Therapeutics Inc (NASDAQ:OMGA) has a market capitalization of $2.69 Million ($2.69 Million) as of May 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #29342 globally and #5738 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Omega Therapeutics Inc's stock price $0.05 by its total outstanding shares 55366200 (55.37 Million). Analyse cash flow conversion of Omega Therapeutics Inc to see how efficiently the company converts income to cash.
Omega Therapeutics Inc Market Cap History: 2021 to 2025
Omega Therapeutics Inc's market capitalization history from 2021 to 2025. Data shows change from $627.30 Million to $2.69 Million (-78.72% CAGR).
Omega Therapeutics Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Omega Therapeutics Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
53.86x
Omega Therapeutics Inc's market cap is 53.86 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $627.30 Million | $144.00K | -$69.16 Million | 4356.24x | N/A |
| 2022 | $316.14 Million | $2.07 Million | -$102.64 Million | 152.50x | N/A |
| 2023 | $166.65 Million | $3.09 Million | -$97.43 Million | 53.86x | N/A |
Competitor Companies of OMGA by Market Capitalization
Companies near Omega Therapeutics Inc in the global market cap rankings as of May 4, 2026.
Key companies related to Omega Therapeutics Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #223 globally with a market cap of $107.56 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #367 globally with a market cap of $72.88 Billion USD.
- UCB SA (BR:UCB): Ranked #517 globally with a market cap of $51.45 Billion USD ( €44.01 Billion EUR).
- argenx NV ADR (NASDAQ:ARGX): Ranked #568 globally with a market cap of $45.97 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #223 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $107.56 Billion | $423.92 |
| #367 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $72.88 Billion | $701.42 |
| #517 | UCB SA | BR:UCB | $51.45 Billion | €231.20 |
| #568 | argenx NV ADR | NASDAQ:ARGX | $45.97 Billion | $787.95 |
Omega Therapeutics Inc Historical Marketcap From 2021 to 2025
Between 2021 and today, Omega Therapeutics Inc's market cap moved from $627.30 Million to $ 2.69 Million, with a yearly change of -78.72%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $2.69 Million | -93.50% |
| 2024 | $41.28 Million | -75.23% |
| 2023 | $166.65 Million | -47.29% |
| 2022 | $316.14 Million | -49.60% |
| 2021 | $627.30 Million | -- |
End of Day Market Cap According to Different Sources
On Apr 27th, 2026 the market cap of Omega Therapeutics Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.69 Million USD |
| MoneyControl | $2.69 Million USD |
| MarketWatch | $2.69 Million USD |
| marketcap.company | $2.69 Million USD |
| Reuters | $2.69 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Omega Therapeutics Inc
Omega Therapeutics, Inc. operates as a clinical-stage biotechnology company. The company's OMEGA platform enables control of fundamental epigenetic processes to correct the root cause of disease by restoring aberrant gene expression to a range without altering native nucleic acid sequences. It also develops OTX-2002 for hepatocellular carcinoma; OTX-2101 for non-small cell lung cancer; omega epig… Read more